Clinical Trials Browser

Mesothelioma, Malignant × ARQ 197 × Thoracic × Clear all

NCT02049060 2021-01-22

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Phase 1/2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT01861301 2016-10-24

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Phase 2 Terminated

18 enrolled 7 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural